상세 보기
Clinical and biomarker results from E7386 study 102: Global dose-expansion cohort of E7386+lenvatinib (LEN) in patients (pts) with advanced/recurrent endometrial cancer (aEC) that progressed on platinum-based chemotherapy (PBC) and an anti-PD-(L)1 immunotherapy (IO)
- Lee, J-Y.;
- Hasegawa, K.;
- Kim, B-G.;
- Berman, B.;
- Suzuki, S.;
- 외 12명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- Clinical and biomarker results from E7386 study 102: Global dose-expansion cohort of E7386+lenvatinib (LEN) in patients (pts) with advanced/recurrent endometrial cancer (aEC) that progressed on platinum-based chemotherapy (PBC) and an anti-PD-(L)1 immunotherapy (IO)
- 저자
- Lee, J-Y.; Hasegawa, K.; Kim, B-G.; Berman, B.; Suzuki, S.; Corr, B. R.; Yunokawa, M.; Orr, D.; Yamamoto, N.; Soliman, P.; Miller, D. S.; Potdar, A.; Shen, J.; Dutta, L.; Wu, J.; McKenzie, J.; Makker, V.
- 발행일
- 2025-09
- 유형
- Meeting Abstract
- 권
- 36